Literature DB >> 16492701

The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.

Christopher R McCartney1, Kathleen A Prendergast, Sandhya Chhabra, Christine A Eagleson, Richard Yoo, R Jeffrey Chang, Carol M Foster, John C Marshall.   

Abstract

CONTEXT: Adolescent hyperandrogenemia is considered a forerunner of adult polycystic ovary syndrome, but its etiology remains uncertain.
OBJECTIVE: Our objective was to explore the hypothesis that peripubertal obesity is associated with hyperandrogenemia. DESIGN AND
SETTING: We performed a cross-sectional analysis of data obtained at General Clinical Research Centers.
SUBJECTS: Subjects were 41 obese [body mass index (BMI) for age, >or=95%] and 35 normal-weight (BMI for age, <95%) peripubertal girls. INTERVENTION: We used pooled blood samples (approximately 0500-0700 h; n = 64) while fasting or single morning (fasting) samples (n = 12). MAIN OUTCOME MEASURES: We assessed adiposity and androgen concentrations.
RESULTS: BMI correlated with total testosterone (T) (r(s) = 0.59), SHBG (r(s) = -0.69), and free T (r(s) = 0.69); free T was three times as great in obese girls compared with normal-weight girls (P < 0.0001 for all). BMI correlated with insulin (r(s) = 0.52); both insulin and LH correlated with free T (r(s) = 0.45 and 0.44, respectively; P < 0.001 for all). When analyzing early pubertal girls (pubertal stages 1-3; n = 36) alone, BMI correlated with total T (r(s) = 0.65), SHBG (r(s) = -0.74), and free T (r(s) = 0.75); free T was five times as great in obese early-pubertal girls (P < 0.001 for all). BMI correlated with insulin (r(s) = 0.65), and insulin correlated with free T (r(s) = 0.63, P < 0.01 for both). BMI correlated with free T while simultaneously adjusting for age, pubertal stage, insulin, LH, and dehydroepiandrosterone sulfate.
CONCLUSION: Peripubertal obesity is associated with marked hyperandrogenemia, which is especially pronounced in early puberty.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492701     DOI: 10.1210/jc.2005-1852

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  57 in total

Review 1.  Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Authors:  Selma F Witchel; Sergio E Recabarren; Frank González; Evanthia Diamanti-Kandarakis; Kai I Cheang; Antoni J Duleba; Richard S Legro; Roy Homburg; Renato Pasquali; Rogerio A Lobo; Christos C Zouboulis; Fahrettin Kelestimur; Franca Fruzzetti; Walter Futterweit; Robert J Norman; David H Abbott
Journal:  Endocrine       Date:  2012-06-04       Impact factor: 3.633

2.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

3.  Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants.

Authors:  Karen L Knudsen; Susan K Blank; Christine Burt Solorzano; James T Patrie; R Jeffrey Chang; Sonia Caprio; John C Marshall; Christopher R McCartney
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

4.  Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives.

Authors:  Laura C Torchen; Naomi R Fogel; Wendy J Brickman; Rodis Paparodis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

Review 5.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

6.  Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion.

Authors:  C M Burt Solorzano; C R McCartney; S K Blank; K L Knudsen; J C Marshall
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

7.  Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls.

Authors:  Christopher R McCartney; Kathleen A Prendergast; Susan K Blank; Kristin D Helm; Sandhya Chhabra; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

8.  Androgen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by high-fat diet in mice.

Authors:  Diana S Brill; Suzanne M Moenter
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

9.  Chronic combined hyperandrogenemia and western-style diet in young female rhesus macaques causes greater metabolic impairments compared to either treatment alone.

Authors:  C A True; D L Takahashi; S E Burns; E C Mishler; K R Bond; M C Wilcox; A R Calhoun; L A Bader; T A Dean; N D Ryan; O D Slayden; J L Cameron; R L Stouffer
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

10.  Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls--implications for regulation of pubertal maturation.

Authors:  Susan K Blank; Christopher R McCartney; Sandhya Chhabra; Kristin D Helm; Christine A Eagleson; R Jeffrey Chang; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.